临床实践指南对特发性肺纤维化诊断和治疗的影响。来自西班牙肺病与胸外科学会(SEPAR)登记处的数据。

Myriam Aburto , José Antonio Rodríguez-Portal , Estrella Fernandez-Fabrellas , Raquel García Sevila , Susana Herrera Lara , Elena Bollo de Miguel , José María González Ruiz , María Molina-Molina , Belén Safont Muñoz , Raul Godoy Mayoral , Ana Dolores Romero Ortiz , María José Soler Sempere , Diego Castillo Villegas , Javier Gaudó Navarro , Laura Tomás López , Belén Nuñez Sanchez , Zulema Palacios Hidalgo , Jacobo Sellares Torres , Lirios Sacristán Bou , María Asunción Nieto Barbero , Claudia Valenzuela
{"title":"临床实践指南对特发性肺纤维化诊断和治疗的影响。来自西班牙肺病与胸外科学会(SEPAR)登记处的数据。","authors":"Myriam Aburto ,&nbsp;José Antonio Rodríguez-Portal ,&nbsp;Estrella Fernandez-Fabrellas ,&nbsp;Raquel García Sevila ,&nbsp;Susana Herrera Lara ,&nbsp;Elena Bollo de Miguel ,&nbsp;José María González Ruiz ,&nbsp;María Molina-Molina ,&nbsp;Belén Safont Muñoz ,&nbsp;Raul Godoy Mayoral ,&nbsp;Ana Dolores Romero Ortiz ,&nbsp;María José Soler Sempere ,&nbsp;Diego Castillo Villegas ,&nbsp;Javier Gaudó Navarro ,&nbsp;Laura Tomás López ,&nbsp;Belén Nuñez Sanchez ,&nbsp;Zulema Palacios Hidalgo ,&nbsp;Jacobo Sellares Torres ,&nbsp;Lirios Sacristán Bou ,&nbsp;María Asunción Nieto Barbero ,&nbsp;Claudia Valenzuela","doi":"10.1016/j.opresp.2024.100334","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>The objective of the study was to analyze the diagnostic process and the time until the start of treatment of patients with idiopathic pulmonary fibrosis in relation to the publication of successive clinical practice guide.</p></div><div><h3>Material and methods</h3><p>Multicenter, observational, ambispective study, in which patients includes in the idiopathic pulmonary fibrosis registry of the Spanish Society of Pulmonologist and Thoracic Surgery were analyzed. An electronic data collection notebook was enabled on the society's website. Sociodemographic and clinical variables were collected at diagnosis and follow-up of the patients.</p></div><div><h3>Results</h3><p>From January 2012 to december 2019, 1064 patients were included in the registry, with 929 finally analyzed. The diagnosis process varied depending on the year in which it was performed, and the radiological pattern observed in the high-resolution computed tomography. Up to 26.3% of the cases (244) were diagnosed with chest high-resolution computed tomography and clinical evaluation. Surgical biopsy was used up to 50.2% of cases diagnosed before 2011, while it has been used in 14.2% since 2018. The median time from the onset of symptoms to diagnosis was 360 days (IQR 120-720), taking more than 2 years in the 21.0% of patients. A percentage of 79.4 of patients received antifibrotic treatment. The average time from diagnosis to the antifibrotic treatment has been 309<!--> <!-->±<!--> <!-->596.5 days, with a median of 49 (IQR 0-307).</p></div><div><h3>Conclusions</h3><p>The diagnostic process, including the time until diagnosis and the type of test used, has changed from 2011 to 2019, probably due to advances in clinical research and the publication of diagnostic-therapeutic consensus guidelines.</p></div>","PeriodicalId":34317,"journal":{"name":"Open Respiratory Archives","volume":"6 3","pages":"Article 100334"},"PeriodicalIF":0.0000,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2659663624000377/pdfft?md5=3830c625fed73c227b9b6ede3894cb8e&pid=1-s2.0-S2659663624000377-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Influencia de las guías de práctica clínica en el diagnóstico y tratamiento de la fibrosis pulmonar idiopática. Datos del Registro de la Sociedad Española de Neumología y Cirugía Torácica\",\"authors\":\"Myriam Aburto ,&nbsp;José Antonio Rodríguez-Portal ,&nbsp;Estrella Fernandez-Fabrellas ,&nbsp;Raquel García Sevila ,&nbsp;Susana Herrera Lara ,&nbsp;Elena Bollo de Miguel ,&nbsp;José María González Ruiz ,&nbsp;María Molina-Molina ,&nbsp;Belén Safont Muñoz ,&nbsp;Raul Godoy Mayoral ,&nbsp;Ana Dolores Romero Ortiz ,&nbsp;María José Soler Sempere ,&nbsp;Diego Castillo Villegas ,&nbsp;Javier Gaudó Navarro ,&nbsp;Laura Tomás López ,&nbsp;Belén Nuñez Sanchez ,&nbsp;Zulema Palacios Hidalgo ,&nbsp;Jacobo Sellares Torres ,&nbsp;Lirios Sacristán Bou ,&nbsp;María Asunción Nieto Barbero ,&nbsp;Claudia Valenzuela\",\"doi\":\"10.1016/j.opresp.2024.100334\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>The objective of the study was to analyze the diagnostic process and the time until the start of treatment of patients with idiopathic pulmonary fibrosis in relation to the publication of successive clinical practice guide.</p></div><div><h3>Material and methods</h3><p>Multicenter, observational, ambispective study, in which patients includes in the idiopathic pulmonary fibrosis registry of the Spanish Society of Pulmonologist and Thoracic Surgery were analyzed. An electronic data collection notebook was enabled on the society's website. Sociodemographic and clinical variables were collected at diagnosis and follow-up of the patients.</p></div><div><h3>Results</h3><p>From January 2012 to december 2019, 1064 patients were included in the registry, with 929 finally analyzed. The diagnosis process varied depending on the year in which it was performed, and the radiological pattern observed in the high-resolution computed tomography. Up to 26.3% of the cases (244) were diagnosed with chest high-resolution computed tomography and clinical evaluation. Surgical biopsy was used up to 50.2% of cases diagnosed before 2011, while it has been used in 14.2% since 2018. The median time from the onset of symptoms to diagnosis was 360 days (IQR 120-720), taking more than 2 years in the 21.0% of patients. A percentage of 79.4 of patients received antifibrotic treatment. The average time from diagnosis to the antifibrotic treatment has been 309<!--> <!-->±<!--> <!-->596.5 days, with a median of 49 (IQR 0-307).</p></div><div><h3>Conclusions</h3><p>The diagnostic process, including the time until diagnosis and the type of test used, has changed from 2011 to 2019, probably due to advances in clinical research and the publication of diagnostic-therapeutic consensus guidelines.</p></div>\",\"PeriodicalId\":34317,\"journal\":{\"name\":\"Open Respiratory Archives\",\"volume\":\"6 3\",\"pages\":\"Article 100334\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2659663624000377/pdfft?md5=3830c625fed73c227b9b6ede3894cb8e&pid=1-s2.0-S2659663624000377-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Respiratory Archives\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2659663624000377\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Respiratory Archives","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2659663624000377","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

该研究旨在分析特发性肺纤维化患者的诊断过程和开始治疗的时间与后续临床实践指南的发布之间的关系。材料和方法该研究是一项多中心、观察性、前瞻性研究,对西班牙肺科和胸外科学会特发性肺纤维化登记处的患者进行了分析。该学会的网站启用了电子数据收集笔记本。结果从2012年1月至2019年12月,共有1064名患者被纳入登记册,最终分析了929名患者。诊断过程因进行诊断的年份和高分辨率计算机断层扫描观察到的放射学模式而异。高达 26.3% 的病例(244 例)是通过胸部高分辨率计算机断层扫描和临床评估确诊的。在2011年之前确诊的病例中,50.2%采用了手术活检,而自2018年以来,14.2%采用了手术活检。从症状出现到确诊的中位时间为 360 天(IQR 120-720),21.0% 的患者超过 2 年。79.4%的患者接受了抗纤维化治疗。从诊断到接受抗纤维化治疗的平均时间为309±596.5天,中位数为49天(IQR 0-307)。结论可能是由于临床研究的进展和诊断治疗共识指南的发布,诊断过程,包括诊断前的时间和使用的检测类型,从2011年到2019年发生了变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Influencia de las guías de práctica clínica en el diagnóstico y tratamiento de la fibrosis pulmonar idiopática. Datos del Registro de la Sociedad Española de Neumología y Cirugía Torácica

Objective

The objective of the study was to analyze the diagnostic process and the time until the start of treatment of patients with idiopathic pulmonary fibrosis in relation to the publication of successive clinical practice guide.

Material and methods

Multicenter, observational, ambispective study, in which patients includes in the idiopathic pulmonary fibrosis registry of the Spanish Society of Pulmonologist and Thoracic Surgery were analyzed. An electronic data collection notebook was enabled on the society's website. Sociodemographic and clinical variables were collected at diagnosis and follow-up of the patients.

Results

From January 2012 to december 2019, 1064 patients were included in the registry, with 929 finally analyzed. The diagnosis process varied depending on the year in which it was performed, and the radiological pattern observed in the high-resolution computed tomography. Up to 26.3% of the cases (244) were diagnosed with chest high-resolution computed tomography and clinical evaluation. Surgical biopsy was used up to 50.2% of cases diagnosed before 2011, while it has been used in 14.2% since 2018. The median time from the onset of symptoms to diagnosis was 360 days (IQR 120-720), taking more than 2 years in the 21.0% of patients. A percentage of 79.4 of patients received antifibrotic treatment. The average time from diagnosis to the antifibrotic treatment has been 309 ± 596.5 days, with a median of 49 (IQR 0-307).

Conclusions

The diagnostic process, including the time until diagnosis and the type of test used, has changed from 2011 to 2019, probably due to advances in clinical research and the publication of diagnostic-therapeutic consensus guidelines.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Open Respiratory Archives
Open Respiratory Archives Medicine-Pulmonary and Respiratory Medicine
CiteScore
1.10
自引率
0.00%
发文量
58
审稿时长
51 days
期刊最新文献
New Frontiers in High-Flow Therapy Personalized Medicine in Severe Asthma: Bridging the Gaps COPD Exacerbation by SARS-CoV-2. A Cause of Future Poor Disease Control? Review of Complications of Endobronchial Ultrasound-Fine Needle Aspiration: A Case of Purulent Pericarditis Prognostic Value of Consolidation in Lung Tomography in Patients With Acute Respiratory Distress Syndrome
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1